What is Catalyst Pharmaceutical's total revenue?

Catalyst Pharmaceutical (CPRX) reported total revenue of $149.39M in Q1 2026.

How has Catalyst Pharmaceutical's total revenue changed year-over-year?

Catalyst Pharmaceutical's total revenue increased by 5.6% year-over-year, from $141.42M to $149.39M.

What is the long-term trend for Catalyst Pharmaceutical's total revenue?

Over 4 years (2021 to 2025), Catalyst Pharmaceutical's total revenue has grown at a 43.0% compound annual growth rate (CAGR), from $140.83M to $588.99M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Catalyst Pharmaceutical CPRX Total Revenue

Total Revenue at other companies

PTC TherapeuticsPTCT

$272.55M-76.8%

Acadia PharmaceuticalsACAD

$268.06M+9.7%

Scholar RockSRRK

$0—

Amneal Pharmaceuticals, Inc.AMRX

$722.52M+3.9%

Rhythm Pharmaceuticals, Inc.RYTM

$60.11M+83.8%

Mirum Pharmaceuticals, Inc.MIRM

$159.88M+43.3%

Segments

By product

See full

Product Revenue Net$149.34M+5.6%

Firdapse$98.86M+18.1%

Agamree$36.71M+66.6%

Fycompa$13.77M-61.3%

Other financials

Income statement

See full

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/E17.4×-1.6×

P/S6.4×-0.6×

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's total revenue?: Catalyst Pharmaceutical (CPRX) reported total revenue of $149.39M in Q1 2026.
How has Catalyst Pharmaceutical's total revenue changed year-over-year?: Catalyst Pharmaceutical's total revenue increased by 5.6% year-over-year, from $141.42M to $149.39M.
What is the long-term trend for Catalyst Pharmaceutical's total revenue?: Over 4 years (2021 to 2025), Catalyst Pharmaceutical's total revenue has grown at a 43.0% compound annual growth rate (CAGR), from $140.83M to $588.99M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.